BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8634988)

  • 1. Prognostic factors of early stage cervical cancer treated by radical hysterectomy.
    Sevin BU; Nadji M; Lampe B; Lu Y; Hilsenbeck S; Koechli OR; Averette HE
    Cancer; 1995 Nov; 76(10 Suppl):1978-86. PubMed ID: 8634988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis.
    Sevin BU; Lu Y; Bloch DA; Nadji M; Koechli OR; Averette HE
    Cancer; 1996 Oct; 78(7):1438-46. PubMed ID: 8839549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix.
    Sevin BU; Method MW; Nadji M; Lu Y; Averette HA
    Cancer; 1996 Apr; 77(8):1489-93. PubMed ID: 8608533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
    Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
    Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy.
    Metindir J; Bilir G
    Eur J Gynaecol Oncol; 2007; 28(1):28-32. PubMed ID: 17375702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma.
    Kenter GG; Hellebrekers BW; Zwinderman KH; van de Vijver M; Peters LA; Trimbos JB
    Acta Obstet Gynecol Scand; 2000 Jan; 79(1):72-6. PubMed ID: 10646820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the relationship between clinicopathological features and pelvic lymph node metastasis in patients with early stage squamous cell carcinoma of the uterine cervix].
    Tian QF; Wang XY; Lü WG; Ye F; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):760-3. PubMed ID: 19087544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P; Tripcony L; Nicklin J
    Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
    Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
    Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and prognostic factors comparing stage IB 1 versus stage IB 2 cervical cancer treated with primary radical hysterectomy.
    Srisomboon J; Kietpeerakool C; Suprasert P; Manopanya M; Siriaree S; Charoenkwan K; Cheewakriangkrai C; Sae-Teng C
    Asian Pac J Cancer Prev; 2011; 12(7):1753-6. PubMed ID: 22126559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.